W Timothy Garvey

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 52

Top Venues

Diabetes care

Obesity (Silver Spring, Md.)

Pediatric exercise science

Diabetes, obesity & metabolism

University of California San Diego Health Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Diego Health Sciences

United States

Clinical and Research Fellow :: Endocrinology and Metabolism

University of Colorado Denver School of Medicine

United States

Clinical and Research Fellowship :: Endocrinology and Metabolism

Barnes-Jewish Hospital

United States

Internship & Residency :: Internal Medicine

Publications

W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care 47 (4) (2024)
W Timothy Garvey, Robert M Cohen
Response to Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570. Diabetes care 47 (9) (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care 47 (4) (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care 47 (4) (2024)
W Timothy Garvey, Robert M Cohen
Response to Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570. Diabetes care 47 (9) (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care 47 (4) (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care 47 (4) (2024)
W Timothy Garvey, Cathy D Mahle, Trevor Bell, Robert F Kushner
Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP-1, GIP receptor agonists, and dual agonists. Obesity science & practice 10 (3) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care (2024)
W Timothy Garvey, Cathy D Mahle, Trevor Bell, Robert F Kushner
Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP-1, GIP receptor agonists, and dual agonists. Obesity science & practice 10 (3) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care 47 (4) (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
W Timothy Garvey, Robert M Cohen
Response to Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570. Diabetes care 47 (9) (2024)
W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew J Ahmann, Priscilla A Hollander, Jonathan Krakoff, Catherine L Martin, Elizabeth R Seaquist, Michael W Steffes, John M Lachin, null null
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes care (2024)
Sean Wharton, Rachel L Batterham, Meena Bhatta, Silvio Buscemi, Louise N Christensen, Juan P Frias, Esteban Jódar, Kristian Kandler, Georgia Rigas, Thomas A Wadden, W Timothy Garvey
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring, Md.) 31 (3) (2023)
Nina Kim, Abdalla Aly, Chris Craver, W Timothy Garvey
Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020. Journal of medical economics (2023)
Sean Wharton, Rachel L Batterham, Meena Bhatta, Silvio Buscemi, Louise N Christensen, Juan P Frias, Esteban Jódar, Kristian Kandler, Georgia Rigas, Thomas A Wadden, W Timothy Garvey
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring, Md.) 31 (3) (2023)
Emily R Hankosky, Hui Wang, Lisa M Neff, Hong Kan, Fangyu Wang, Nadia N Ahmad, Adam Stefanski, W Timothy Garvey
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial. Diabetes, obesity & metabolism (2023)
Nina Kim, Abdalla Aly, Chris Craver, W Timothy Garvey
Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020. Journal of medical economics 26 (1) (2023)
Lua Wilkinson, Thomas Holst-Hansen, Peter N Laursen, Anders R Rinnov, Rachel L Batterham, W Timothy Garvey
Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity. Obesity (Silver Spring, Md.) 31 (9) (2023)
Sean Wharton, Rachel L Batterham, Meena Bhatta, Silvio Buscemi, Louise N Christensen, Juan P Frias, Esteban Jódar, Kristian Kandler, Georgia Rigas, Thomas A Wadden, W Timothy Garvey
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring, Md.) (2023)
Sean Wharton, Rachel L Batterham, Meena Bhatta, Silvio Buscemi, Louise N Christensen, Juan P Frias, Esteban Jódar, Kristian Kandler, Georgia Rigas, Thomas A Wadden, W Timothy Garvey
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring, Md.) 31 (3) (2023)
Bethany A Moore, Makenzie L Callahan, Samantha L Martin, Alysha B Everett, W Timothy Garvey, Paula C Chandler-Laney
Associations Among Physical Activity, Adiposity, and Insulin Resistance in Children Exposed In Utero to Maternal Obesity With and Without Gestational Diabetes. Pediatric exercise science (2022)
W Timothy Garvey, Rachel L Batterham, Meena Bhatta, Silvio Buscemi, Louise N Christensen, Juan P Frias, Esteban Jódar, Kristian Kandler, Georgia Rigas, Thomas A Wadden, Sean Wharton, null null
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature medicine 28 (10) (2022)
Bethany A Moore, Makenzie L Callahan, Samantha L Martin, Alysha B Everett, W Timothy Garvey, Paula C Chandler-Laney
Associations Among Physical Activity, Adiposity, and Insulin Resistance in Children Exposed In Utero to Maternal Obesity With and Without Gestational Diabetes. Pediatric exercise science (2022)
Bethany A Moore, Makenzie L Callahan, Samantha L Martin, Alysha B Everett, W Timothy Garvey, Paula C Chandler-Laney
Associations Among Physical Activity, Adiposity, and Insulin Resistance in Children Exposed In Utero to Maternal Obesity With and Without Gestational Diabetes. Pediatric exercise science (2022)
Bethany A Moore, Makenzie L Callahan, Samantha L Martin, Alysha B Everett, W Timothy Garvey, Paula C Chandler-Laney
Associations Among Physical Activity, Adiposity, and Insulin Resistance in Children Exposed In Utero to Maternal Obesity With and Without Gestational Diabetes. Pediatric exercise science (2022)
Bethany A Moore, Makenzie L Callahan, Samantha L Martin, Alysha B Everett, W Timothy Garvey, Paula C Chandler-Laney
Associations Among Physical Activity, Adiposity, and Insulin Resistance in Children Exposed In Utero to Maternal Obesity With and Without Gestational Diabetes. Pediatric exercise science (2022)
W Timothy Garvey, Guillermo E Umpierrez, Julia P Dunn, Anita Y M Kwan, Oralee J Varnado, Manige Konig, Joshua A Levine
Examining the evidence for weight management in individuals with type 2 diabetes. Diabetes, obesity & metabolism 24 (8) (2022)
Carrie R Howell, Li Zhang, Nengjun Yi, Tapan Mehta, Andrea L Cherrington, W Timothy Garvey
Associations between cardiometabolic disease severity, social determinants of health (SDoH), and poor COVID-19 outcomes. Obesity (Silver Spring, Md.) 30 (7) (2022)
W Timothy Garvey
New Horizons A New Paradigm for Treating to Target with Second-Generation Obesity Medications. The Journal of clinical endocrinology and metabolism (2021)
W Timothy Garvey
Long-term health benefits of intensive lifestyle intervention in the Look AHEAD study. Obesity (Silver Spring, Md.) 29 (8) (2021)
W Timothy Garvey, Andreas L Birkenfeld, Dror Dicker, Geltrude Mingrone, Sue D Pedersen, Altynai Satylganova, Dorthe Skovgaard, Danny Sugimoto, Camilla Jensen, Ofri Mosenzon
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes care 43 (5) (2020)
Robert F Kushner, Salvatore Calanna, Melanie Davies, Dror Dicker, W Timothy Garvey, Bryan Goldman, Ildiko Lingvay, Mette Thomsen, Thomas A Wadden, Sean Wharton, John P H Wilding, Domenica Rubino
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity (Silver Spring, Md.) 28 (6) (2020)
W Timothy Garvey, Jeffrey I Mechanick
Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity. Obesity (Silver Spring, Md.) 28 (3) (2020)
Elizabeth L Ciemins, Vaishali Joshi, John K Cuddeback, Robert F Kushner, Deborah B Horn, W Timothy Garvey
Diagnosing Obesity as a First Step to Weight Loss: An Observational Study. Obesity (Silver Spring, Md.) 28 (12) (2020)
W Timothy Garvey, Jeffrey I Mechanick
Response to "The Future of Obesity Diagnostic Coding". Obesity (Silver Spring, Md.) 28 (7) (2020)
Aksam Yassin, Ahmad Haider, Karim S Haider, Monica Caliber, Gheorghe Doros, Farid Saad, W Timothy Garvey
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study. Diabetes care 42 (6) (2019)
Fangjian Guo, W Timothy Garvey
Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release. Diabetes care 40 (7) (2017)

W Timothy Garvey.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

W Timothy Garvey